Synthesis and in vitro biological evaluation of novel quinazoline derivatives

Y Zhang, Y Zhang, J Liu, L Chen, L Zhao, B Li… - Bioorganic & Medicinal …, 2017 - Elsevier
A series of novel 4-arylamino-6-(5-substituted furan-2-yl) quinazoline derivatives were
designed, synthesized and evaluated on biological activities in vitro. Compound 2a, 3a and …

6, 7-Dimorpholinoalkoxy quinazoline derivatives as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells

Y Zhang, L Chen, H Xu, X Li, L Zhao, W Wang… - European Journal of …, 2018 - Elsevier
Abstract A series of novel 6, 7-dimorpholinoalkoxy quinazoline derivatives was designed,
synthesized and evaluated as potent EGFR inhibitors. Most of synthesized derivatives …

Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2, 3-dihydro-indole or 1, 2, 3, 4-tetrahydroquinoline as potential …

Y OuYang, W Zou, L Peng, Z Yang, Q Tang… - European Journal of …, 2018 - Elsevier
Eight series of quinazoline derivatives bearing 2, 3-dihydro-indole or 1, 2, 3, 4-
tetrahydroquinoline were designed, synthesized and evaluated for the IC 50 values against …

Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation …

J Chang, H Ren, M Zhao, Y Chong, W Zhao… - European Journal of …, 2017 - Elsevier
anilinoquinazoline-based derivatives represent an attractive scaffold for small molecular
EGFR-TKIs in the field of medicinal chemistry. A series of novel heterocyclic substituted …

Design and synthesis of 4, 6-substituted-(diaphenylamino) quinazolines as potent EGFR inhibitors with antitumor activity

HQ Li, DD Li, X Lu, YY Xu, HL Zhu - Bioorganic & medicinal chemistry, 2012 - Elsevier
A type of novel 4, 6-substituted-(diaphenylamino) quinazolines, which designed based on
the 4-(phenylamino) quinazoline moiety, have been discovered as potential EGFR …

Facile and efficient synthesis and biological evaluation of 4-anilinoquinazoline derivatives as EGFR inhibitors

Z Wang, X Wu, L Wang, J Zhang, J Liu, Z Song… - Bioorganic & Medicinal …, 2016 - Elsevier
Abstract Series of 4-anilinoquinazoline derivatives were conveniently and efficiently
synthesized and their antitumor activities were evaluated by MTT assay in three human …

Design, synthesis, anticancer activity and docking studies of novel quinazoline-based thiazole derivatives as EGFR kinase inhibitors

MS Raghu, HA Swarup, T Shamala, BS Prathibha… - Heliyon, 2023 - cell.com
The in vitro anticancer efficacy of a new series of quinazoline-based thiazole derivatives was
explored. Three cancer cell lines, MCF-7, HepG2, and A548, as well as the normal Vero cell …

Novel 4-arylaminoquinazoline derivatives with (E)-propen-1-yl moiety as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells

L Chen, Y Zhang, J Liu, W Wang, X Li, L Zhao… - European Journal of …, 2017 - Elsevier
A series of novel 4-anilinoquinazoline derivatives with (E)-propen-1-yl moiety were
designed, synthesized and evaluated for biological activities in vitro. Most compounds …

Design and Synthesis of some new 2, 4, 6-trisubstituted quinazoline EGFR inhibitors as targeted anticancer agents

HA Allam, EE Aly, AK Farouk, AM El Kerdawy… - Bioorganic …, 2020 - Elsevier
The present study describes the synthesis of 6-bromo-2-(pyridin-3-yl)-4-substituted
quinazolines starting from 4-chloro derivative VI via the reaction with either phenolic …

Discovery of thiapyran-pyrimidine derivatives as potential EGFR inhibitors

Z Xiao, C Chu, L Zhou, Z Zhou, Q Zhang, F Yang… - Bioorganic & Medicinal …, 2020 - Elsevier
A series of novel thiapyran-pyrimidine derivatives (10a–10h, 11a–11g, 12a–12f, 13a–13f,
14a–14f) were synthesized and their antiproliferative activities were tested. Most of the target …